US · guidance
CMS, Hospice Information for Medicare Part D Plans (OMB 0938-1269), § Hospice Information for Medicare Part D Plans (form)
Hospice Information for Medicare Part D Plans (form)
OMB Control Number 0938-1269
Expires 7/31/2028
SECTION I -HOSPICE INFORMATION TO OVERRIDE AN “HOSPICE A3 REJECT” OR TO UPDATE HOSPICE STATUS
A. P urpose of the form (please check all appropriate boxes ) :
Admission Proactive Rx Communication A3 Reject Override Termination
To: Medicare Part D Plan From: Hospice Provider
Plan Name Hospice Name
PBM Name Address
Phone # ( ) - Phone # ( ) -
Fax # ( ) - Fax # ( ) -
Secure E-Mail NPI
Contact Name Contact Name
Plan Sponsor Website Link:
B. Patient Information Prescriber Information
Patient Name Prescriber Name
Patient DOB Prescriber NPI
Patient ID # (MBI) Practice Name
Hospice Admit Date Practice Address
Hospice Discharge Date Contact Name
Principal Diagnosis Code Practice Phone Number ( ) -
Other Diagnosis Code (s) Practice Fax # ( ) -
Unrelated Diagnosis
Code (s)
Hospice Affiliated
YES NO
For change in hospice status update documentation is required. Please check to indicate which document is attached.
Notice of Election Notice of Termination /Revocation
C. Hospice Pharmacy Benefit Manager (PBM) Information
PBM Name BIN Cardholder ID
PBM Phone # ( ) - PCN Group ID
D. Prior Authorization Process: Enter a separate line for each Analgesic, Antinauseant (antiemetic), Laxative, and Antianxiety drug (anxiolytic)
Medication that is Unrelated to Terminal Prognosis . Drugs outside of these four classes do not require prior authorization.
Medication Name and Strength Dosing Schedule Quantity/
Month
Rationale to Support the Medication is Unrelated to Terminal
Prognosis (Optional)
E. Signature of Hospice Representative or Prescriber (Required).
Representative Date / /
Title _______________________________________________
Prescriber* Date / / _
*If the prescriber of the medication is unaffiliated with the Hospice provider, has the prescriber confirmed with
Yes Nothe Hospice provider that the medication is unrelated to the terminal prognosis?
/
Hospice Name
Patient Name
SECTION II – PLAN OF CARE (Optional)
Hospice NPI
Patient ID# () / /Patient DOB
Additional Medications Under Hospice Plan of Care and Designation of Financial Responsibility
Medication Name and Strength Hospice Patient Medication Name and Strength Hospice Patient
Signature of Hospice Representative
Representative Date / /
Signature of Beneficiary or Beneficiary Authorized R epresentative
Beneficiary/Representative Date /
History
Standardized form and instructions for Part D coverage of drugs for beneficiaries enrolled in hospice (OMB control number 0938-1269), as posted on the CMS Hospice page 2026-09-17.
Provenance
- Source
- cms.gov
- Retrieved
- 2026-09-17
- Edition
- hospice-memos-2026-09-17
- Content hash
63e727672784d12ee24dab65a90266d18d9558d03dc431086e989ae5875288eb
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.